| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.401.1 | To remember the etiopathogenesis and clinical presentation of gastrointestinal and haematological diseases. |
| 2 | CO.401.2 | To summarize the diagnosis and therapeutic approaches of gastrointestinal and haematological diseases. |
| 3 | CO.401.3 | To identify the causes, pathogenesis and clinical manifestations of neurological and psychiatric diseases. |
| 4 | CO.401.4 | Tosimplify understanding on diagnosis, desired outcomes and management of neurological and psychiatric diseases |
| 5 | CO.401.5 | To explain the physiology of pain pathway and management of pain, neuralgia and headaches. |
| 6 | CO.401.6 | To develop skills on evidence-based practice in diseases management to become a competent pharmacist. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.407.1 | To understand the therapeutic approaches and treatment alternatives in the management of gastrointestinal diseases. |
| 2 | CO.407.2 | Torelate the concept of pharmaceutical care to identify therapeutic problems in haematological diseases. |
| 3 | CO.407.3 | To apply the knowledge to develop therapeutic decision-making skills in gastrointestinal and haematological diseases. |
| 4 | CO.407.4 | To take part in drug related problem identification and problem- solving skills in neurological diseases. |
| 5 | CO.407.5 | To prioritize the rational pharmaco therapeutic alternatives in the management of psychiatric diseases. |
| 6 | CO.407.6 | To develop skills on drug of choice and patient education in management of diseases. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.402.1 | To define the structure, organization and functions of hospital and hospital pharmacist |
| 2 | CO.402.2 | To understand and involve in the preparation and implementation of budget, inventory control various drug policies |
| 3 | CO.402.3 | To make use of various hospital drug policies to develop hospital pharmacy news letters |
| 4 | CO.402.4 | To list out various drug distribution methods for inpatients and outpatients including narcotic and controlled drugs. |
| 5 | CO.402.5 | To prioritize the procurement, manufacturing and storage process of various formulations and handling of radio pharmaceuticals |
| 6 | CO.402.6 | To develop programmes for professional upraising continuously, inter professional relations in hospitals. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.408.1 | To understand various drug distribution systems in hospital. |
| 2 | CO.408.2 | To extend the professional practice management skills in hospital pharmacy. |
| 3 | CO.408.3 | To utilize various methods for the preparation and labelling of pharmaceutical products such as powders and intravenous solutions |
| 4 | CO.408.4 | To recommend the solutions to overcome the drug interaction and adverse drug reactions. |
| 5 | CO.408.5 | To appreciate various store management and inventory control. |
| 6 | CO.408.6 | To solve drug related problems through prescription analysis and individualized dose. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.403.1 | To understand and explain the daily activities of clinical pharmacist and to monitor the patient rug therapy through medication chart review and clinical review. |
| 2 | CO.403.2 | To obtain medication history interview and counsel the patients on various diseases and lifestyle modifications and by applying communication skills. |
| 3 | CO.403.3 | To provide response to a drug and poison information queries using modified systemic approach and to gain ability to establish a drug and poison information center. |
| 4 | CO.403.4 | To interpret selected laboratory results of specific disease states mentioned and to report ADRs and understand the process of pharmaco vigilance. |
| 5 | CO.403.5 | To identify and resolve drug related problems and medication errors. |
| 6 | CO.403.6 | To critically evaluate biomedical literature in order to get an unbiased clinical evidence to develop individualized pharmaceutical care plan. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.409.1 | To create awareness in patients by counselling them on various diseases and drugs using clinical knowledge and communication skills. |
| 2 | CO.409.2 | To conduct comprehensive and meticulous medication history interview for the preparation of individualized pharmaceutical care plan. |
| 3 | CO.409.3 | To interpret laboratory results of specific disease states mentioned and correlating with patient drug therapy while monitoring disease progression. |
| 4 | CO.409.4 | To provide response to a drug and poison information queries using modified systemic approach by critically appraising the biomedical literature. |
| 5 | CO.409.5 | To report and assess causality of adverse drug reactions to establish a causal relation between an ADR and a drug. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.404.1 | To define the concepts of research methodology and sample size determination with report writing. |
| 2 | CO.404..2 | To discuss different types of clinical study designs involved in medical research like case studies, observational studies and interventional studies. |
| 3 | CO.404.3 | To apply the concepts of biostatistics and data graphics along with clinical soft wares like SPSS, SAS to support the research |
| 4 | CO.404.4 | To learn to utilize the computer applications and their advantages in both hospital, community pharmacy. |
| 5 | CO.404.5 | To simplify the understanding of statistical methods in epidemiology and be conscious about its relative, attributable risks |
| 6 | CO.404.6 | To critically evaluate biomedical literature in order to get an unbiased clinical evidence to develop individualized pharmaceutical care plan. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.405.1 | To recall basic concepts of absorption, distribution, metabolism and excretion of drugs. |
| 2 | CO.405.2 | To understand the mechanisms, interpret various factors affecting drug absorption, distribution, metabolism and excretion of drugs. |
| 3 | CO.405.3 | To apply the pharmacokinetic models for the determination of pharmacokinetic parameters. |
| 4 | CO.405.4 | To examine multiple dosage regimens based on pharmacokinetic parameters for maximizing therapeutic effectiveness and patient compliance. |
| 5 | CO.405.5 | To evaluate various pharmacokinetic parameters for the drugs exhibiting saturation kinetics. |
| 6 | CO.405.6 | To design the bioavailability testing protocol of a drug and compare the bioequivalence between marketed products. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.410.1 | To recall the concepts in biopharmaceutics, basic pharmacokinetic parameters and their significance. |
| 2 | CO.410.2 | To interpret the effect of surfactant, diluents, lubricant and polymorphism on rate of drug dissolution. |
| 3 | CO.410.3 | To solve bioavailability parameters of drugs by using plasma data and methods to improve bioavailability. |
| 4 | CO.410.4 | To analyze absorption rate constant, KE, biological half-life, mean residence time and mean absorption time for the given data. |
| 5 | CO.410.5 | To estimate the extent of protein biding by equilibrium dialysis or dynamic dialysis methods. |
| 6 | CO.410.6 | To predict the pharmacokinetic parameters for the given data as per one compartment and two compartment models. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.406.1 | To understand the general principles involved in the management of poisoning with toxicokinetics parameters. |
| 2 | CO.406.2 | To identify the role of antidotes, supportive care, gut decontamination and elimination enhancement in poisoning. |
| 3 | CO.406.3 | To distinguish the clinical symptoms and to plan various managements of pesticides, drugs acting on CNS, hydrocarbons, caustics and radiation poisoning. |
| 4 | CO.406.4 | To categorize the toxic symptoms and management of venomous snake bites, toxicity of plants and contaminated foods and heavy metals. |
| 5 | CO.406.5 | To compare the characteristics and specific standard treatment guideline for the treatment of various toxins. |
| 6 | CO.406.6 | To propose several preventive approaches to reduce unintended poisoning. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.411.1 | To remember and recall the pathophysiology of selected diseases and rationale for drug therapy. |
| 2 | CO.411.2 | To identify various therapeutic approaches for the management of selected diseases. |
| 3 | CO.411.3 | To apply the concepts of various drug therapies and identify the controversies in drug therapy. |
| 4 | CO.411.4 | To distinguish between various disease conditions and analyze the results with drug induced disorders. |
| 5 | CO.411.5 | To select the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy among pediatric, geriatric, pregnant and lactating women. |
| 6 | CO.411.6 | To develop competency to design individual care plan for cardiovascular, respiratory, ocular and hormonal disorders. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.412.1 | To remember and recall the pathophysiology and management of cardiovascular, respiratory, endocrine diseases and viral infections |
| 2 | CO.412.2 | To identify various drug interactions and rationalize the prescription. |
| 3 | CO.412.3 | To plan the quality use of medicines surrounding the therapeutic agents in the treatment of selected diseases |
| 4 | CO.412.4 | To analyze the clinical skills in the therapeutic management of selected disease conditions |
| 5 | CO.412.5 | To prioritize the treatment strategies for better patient outcome and discuss the controversies in treatment |
| 6 | CO.412.6 | To improve the skills on patient – centred approach to improve treatment satisfaction and perform patient counselling |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.501.1 | To study the regulations involved in drug discovery and drug development process. |
| 2 | CO.501.2 | To understand the regulatory guidelines and ethics of clinical trials. |
| 3 | CO.501.3 | To plan and construct pre-clinical trials and clinical trial activities. |
| 4 | CO.501.4 | To distinguish the roles and responsibilities of trial related personnel and designing of clinical trial documents. |
| 5 | CO.501.5 | To compare the regulatory aspect of clinical trials in India with other countries (USA and Europe). |
| 6 | CO.501.6 | To adapt and improve the skills in data management, safety monitoring and reporting to regulatory authorities. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.502.1 | To remember and recall the origin and need; measurement of outcomes in pharmacoepidemiology and pharmacoeconomics. |
| 2 | CO.502.2 | To understand the various concepts of risks in pharmacoepidemiology. |
| 3 | CO.502.3 | To apply the concepts of pharmacoepidemiological methods in conducting various research studies with the help of case studies and available software’s. |
| 4 | CO.502.4 | To distinguish the selected special applications of Pharmaco-epidemiology. |
| 5 | CO.502.5 | To evaluate methods. the outcome by using various Pharmaco economics. |
| 6 | CO.502.6 | To solve various case studies by applying the concepts of pharmacoepidemiology and Pharmacoeconomics in designing a good outcome. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.503.1 | To understand the basics of pharmacokinetics. |
| 2 | CO.503.2 | To demonstrate nomo grams and tabulations and their applications in designing dosage regimens in special populations. |
| 3 | CO.503.3 | To apply the principles of pharmacokinetics in identifying the drug interactions. |
| 4 | CO.503.4 | To analyze GFR, creatinine clearance, extracorporeal removal of drugs and pharmacokinetic considerations in dosing renal and hepatic diseases. |
| 5 | CO.503.5 | To discuss bayesian theory, adaptive methods and pharmacogenetics in developing drug dosage regimens. |
| 6 | CO.503.6 | To develop the skills on individualization of drug dosage regimen in special population by considering TDM indications |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.504.1 | To elicit the patient's chief complaints, history of present illness, past medical history, social, family and occupational histories, complete review of systems for case study analysis. |
| 2 | CO.504.2 | To interpret the laboratory investigations in terms of the related pathophysiology. |
| 3 | CO.504.3 | To build effective and empathetical skills in counseling the patients on their medications and life style modifications. |
| 4 | CO.504.4 | To examine and demonstrate a new patient's case in a focused manner, chronologically developing the present illness, summarizing the pertinent positive and negative findings as well as the differential diagnosis and plans for further testing and treatment. |
| 5 | CO.504.5 | To estimate factors that frequently alter the effects of medications, including drug interactions and compliance problems. |
| 6 | CO.504.6 | To develop an ability to compile an assessment and plan for an individual patient organized by problem, discussing the likely diagnosis and plan of treatment. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.505.1 | To identify the societal issues related to health and pharmaceuticals and to report the aims and objectives of the project. |
| 2 | CO.505.2 | To review and compare the literature on selected topic/problem/issue. |
| 3 | CO.505.3 | To construct research plan and execute it accordingly. |
| 4 | CO.505.4 | To compile and analyze the data applying the knowledge of suitable statistical method to draw conclusion. |
| 5 | CO.505.5 | To measure short-term and long-term outcomes of a specific research to draw conclusion. |
| 6 | CO.505.6 | To propose new solutions and develop recommendations or guidelines to improve societal health outcomes |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | CO.6.0.1 | To relate the clinical knowledge in ward rounds for case analysis. |
| 2 | CO.6.0.2 | To interpret the results of the laboratory tests in terms of the related pathophysiology. |
| 3 | CO.6.0.3 | To interview the patient to provide better patient care by critical analysis. |
| 4 | CO.6.0.4 | To analyse each case to identify the drug related problems and overcome the burden on patients. |
| 5 | CO.6.0.5 | To take a part of health care team to bring better patient outcomes and drug information services. |
| 6 | CO.6.0.6 | To build an ability to choose critical area where interventions required for better pharmaceutical care. |